|Articles|January 2, 2023
- Pharmaceutical Technology, January 2023
- Volume 47
- Issue 1
- Pages: 12
Biologics-Oriented Antibody Discovery Platform
Author(s)Pharmaceutical Technology Editors
Bio-Rad Laboratories’ Pioneer Antibody Discovery Platform is an antibody discovery service specifically designed to develop best-in-class biologic candidates.
Bio-Rad Laboratories Pioneer Antibody Discovery Platform is an antibody discovery service specifically designed to develop best-in-class biologic candidates. The platform, which includes more than 200 billion unique sequences, is capable of identifying high-affinity antibody candidates via Bio-Rad’s SpyDisplay selection technology; this technology is optimized for candidates suitable for drug development.
The platform is tailored to specific client requirements and uses proprietary TrailBlazer technology to provide prototypes of therapeutic antibodies in various formats for streamlined lead identification. Final immunoglobulin G antibodies are delivered functionally characterized with a complete data package and sequences. Customers retain exclusivity and ownership over antibody sequences produced from the platform.
Articles in this issue
almost 3 years ago
Six Approaches Making the Most Significant Impact in the Futurealmost 3 years ago
Opening Up Opportunities in 2023almost 3 years ago
Inhalation Vaccine Developmentalmost 3 years ago
Crossing the Same River Multiple Timesalmost 3 years ago
Predicting Pharma’s Futurealmost 3 years ago
Write it Down, Investigate, and Controlalmost 3 years ago
Cleaning Up in Bio/Pharmaalmost 3 years ago
Setting Goals for Sustainabilityalmost 3 years ago
The Growth and Emergence of Technology in the Outsourcing Spacealmost 3 years ago
A Rocky Road Ahead for FDA and IndustryNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
